Successful completion of preclinical studies is an essential prerequisite for starting clinical trials on humans. Preclinical testing on animals under the strict GLP conditions (GLP – Good Laboratory Practice) is a key and indispensable element in the development of new pharmaceuticals. Centre for Preclinical Testing was founded with the support of Czech Academy of Sciences and it is closely linked with CAS program „Preclinical Testing of Potential Pharmaceuticals“ within Strategy AV21. The Centre offers a complete service for preclinical studies with candidate substances on turnkey basis.

It uses a wide infrastructure and know-how of selected specialised laboratories within the CAS. It provides standard and custom tailored studies to support CTA/MA processes and meet the needs of our clients in pharma (human and veterinary medicinal products), food, medical devices. Non-clinical safety studies and analytical chemistry testing can be performed under GLP requirements. Since its founding in 2017, dozens of pharmacological and toxicological in-vivo studies have been conducted at CPT, helping medicines on their long journey from test tube to patient. 

More information